Sofiane Allali
Paris, 75005, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Concurrent Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: Assessing the Efficacy.
Journal: American journal of clinical oncology
Published: July 16, 2025
Real-world Safety of Concurrent Pembrolizumab and Radiotherapy in Triple-negative Breast Cancer.
Journal: American journal of clinical oncology
Published: June 02, 2025
Hypofractionated whole-breast radiation therapy with simultaneous integrated boost after breast-conserving surgery: preliminary real-life experience of the Radiation Therapy Oncology Group 1005 trial.
Journal: The British journal of radiology
Published: April 27, 2025
Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group.
Journal: International journal of cancer
Published: April 07, 2025
Radiotherapy for patients with pacemakers and implantable cardioverter defibrillators: A review of the recommendations and practical application.
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: January 30, 2025
Evaluating organs-at-risk constraints in hypofractionated locoregional breast cancer radiotherapy with integrated boost.
Journal: The British journal of radiology
Published: January 28, 2025
Long-Term Results of Intensity Modulated Radiotherapy (IMRT) with Helical Tomotherapy in Non-Metastatic Breast Cancer Patients: Final Analysis.
Journal: Cancers
Published: December 30, 2024
Ultra hypofractionated breast radiotherapy according to the Fast-Forward scheme: Excellent early tolerance or delayed skin reactions? Real life experience.
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: November 27, 2024
Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: A Single-center Experience and Review of the Literature.
Journal: American journal of clinical oncology
Published: July 16, 2024
CANTO skin: Evaluation of skin toxicity risk factors in patients treated for breast cancer.
Journal: International journal of cancer
Published: June 18, 2023
CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancer.
Journal: International journal of cancer
Published: March 01, 2022
Last Updated: 09/26/2026